UlrichKSchubartMD
Endocrinology • Bronx, NYDiabetes, Lipid Metabolism
Professor, Medicine, Endocrinology, Albert Einstein College of Medicine
Are you Dr. Schubart?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 44 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
Montefiore Medical Park
1575 Blondell Avenue
Bronx, NY 10461Phone+1 718-405-8260Fax+1 718-405-8278
Summary
- Dr. Ulrich Schubart, MD is an endocrinologist in Bronx, New York. He is currently licensed to practice medicine in New York. He is affiliated with NYC Health + Hospitals / Jacobi, Montefiore Medical Center, and NYC Health + Hospitals / North Central Bronx.
Education & Training
Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Residency, Internal Medicine, 1970 - 1972
Icahn School of Medicine at Mount Sinai (Bronx)Residency, Internal Medicine, 1970 - 1970
SUNY Downstate Health Sciences UniversityInternship, Transitional Year, 1969 - 1969
Freie University Berlin Faculty of MedicineClass of 1967
Certifications & Licensure
NY State Medical License 1974 - 2022
Clinical Trials
- Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus Start of enrollment: 2010 Jun 18
- A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes Start of enrollment: 2014 Feb 01
Publications & Presentations
PubMed
- 22 citationsPregnancy-associated subacute hemorrhage into a prolactinoma resulting in diabetes insipidusRuth Freeman, Barbara Wezenter, Michele Silverstein, Dennis Yi-Shin Kuo, kenneth L. Weiss
Fertility and Sterility. 1992-08-01 - 959 citationsEffect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trialFaramarz Ismail-Beigi, Timothy E. Craven, Mary Ann Banerji, Jan Basile, Jorge Calles
Lancet. 2010-08-07 - 843 citationsEffects of medical therapies on retinopathy progression in type 2 diabetes.Emily Y. Chew, Walter T. Ambrosius, Matthew D. Davis, Ronald P. Danis, Sapna Gangaputra
The New England Journal of Medicine. 2010-07-15
Grant Support
- Metablastin And The Control Of Cell DivisionNational Institute Of Neurological Disorders And Stroke1996–1999
- Role Of P19 In Neuronal DevelopmentNational Institute Of Neurological Disorders And Stroke1988–1992
